Skip links

Blog

liver-cancer:-a-promising-avenue-for-more-effective-immunotherapies

Liver cancer: a promising avenue for more effective immunotherapies

Laval, February 14, 2024 – A research team of Canadian and French scientists, led by INRS professor Maya Saleh, has been investigating immunotherapy resistance in certain patients with hepatocellular carcinoma (HCC) associated with steatotic liver disease. The findings are published in the journal Cell Reports. Credit:
novel-drug-combination-shows-promise-for-advanced-her2-negative-breast-cancer

Novel drug combination shows promise for advanced her2-negative breast cancer

FOR IMMEDIATE RELEASE Credit: From left, Evanthia Roussos Torres, Elizabeth Jaffee, Roisin Connolly and Vered Stearns. FOR IMMEDIATE RELEASE A novel three-drug combination achieved notable responses in patients with advanced HER2-negative breast cancer, according to new research directed by investigators from the Johns Hopkins Kimmel
researchers-characterize-the-immune-landscape-in-cancer

Researchers characterize the immune landscape in cancer

New York, NY [February 14, 2024]—Researchers from the Icahn School of Medicine at Mount Sinai, in collaboration with the Clinical Proteomic Tumor Analysis Consortium of the National Institutes of Health, The University of Texas MD Anderson Cancer Center, Sylvester Comprehensive Cancer Center at the University
pancreatic-cancer-hijacks-a-brain-building-protein

Pancreatic cancer hijacks a brain-building protein

Scientists at Cold Spring Harbor Laboratory (CSHL) and the University of California, Davis have reached a new breakthrough in pancreatic cancer research—eight years in the making. It could help slow the disease’s deadly spread. Credit: Tuveson lab/Cold Spring Harbor Laboratory Scientists at Cold Spring Harbor
Explore
Drag